ArticleBMC pregnancy and childbirth2025
Perinatal depression among women in pregnancy and postpartum periods in Gaborone, Botswana.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionPerinatal depression is an important cause of maternal and infant morbidity. Rates of perinatal depression amongst pregnant and postpartum women in Botswana are not well-documented. We examined the prevalence of symptoms of depression and potential associated factors among pregnant and postpartum women participating in a sexually transmitted infection screening study.
methodsWe conducted a repeated time-point cross-sectional analysis of the Maduo study, a non-randomized clinic-controlled trial evaluating the benefit of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening in Gaborone, Botswana. The Edinburgh Postnatal Depression Scale (EPDS) was used to screen for symptoms of depression at the first antenatal care and 6–8 week postnatal care visit. Prevalence of depression was assessed using EPDS cut-off scores of ≥11 and ≥13. Participants with an EPDS score of ≥13 were referred to local mental health services. We used multivariate logistic regression to identify potential associations with symptoms of perinatal depression (EPDS score ≥13) at first antenatal care visit, 6–8 week postnatal visit and overall, including socioeconomic, pregnancy-related and relationship factors. We also conducted a sensitivity analysis with EPDS score specified as a continuous variable.
resultsAll 500 enrolled women completed at least one EPDS questionnaire during the study: 495 (99%) at first antenatal care and 428 (86%) at the postnatal visit. Median EPDS score was 3 (IQR 1–6) at the first antenatal visit and 2 (IQR 0–5) at the postnatal visit. Similar proportions of women had EPDS scores suggestive of depression at first antenatal (EPDS ≥13, 5% (95% CI 3–7%); EPDS ≥11, 7% (95% CI 5–10%)) and postnatal visits (EPDS ≥13, 3% (95% CI 1–5%); EPDS ≥11, 7% (95% CI 5–10%)), however there was minimal overlap in women with antenatal and postnatal symptoms of depression. Symptoms of depression were strongly associated with experience of intimate partner violence both antenatally (aOR 5.41, 95% CI 1.94–15.10, p = 0.001) and postnatally (aOR 5.18, 95% CI 3.35–8.02, p = < 0.001); whilst symptoms of depression at the first antenatal care visit were also associated with unintended pregnancy (aOR 29.44, 95% CI 2.75–314.6, p = 0.005).
conclusionRates of perinatal depression in this study were lower than estimated rates in Southern Africa. Nonetheless, screening pregnant women for depression as part of routine antenatal care in Botswana provides an opportunity to identify those most in need of support and specialist services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.